A Prospective, Single-centre, Open-label Study to Confirm the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency

• Status: Completed
• Trial end date: 2016-08-27
• Target enrollment: 0
• Participant gender: All

Summary

A Prospective, Single-centre, Open-label Study to Confirm the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in adults with Vitamin D Deficiency

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kwang Dong Pharmaceutical co., ltd.
• Treatments: Cholecalciferol; Ergocalciferols; Vitamin D; Vitamins

Criteria

Inclusion Criteria:

• Subjects with vitamin D deficiency

Exclusion Criteria:

• Subjects who experienced a hypersensitivity to the cholecalciferol

• Subjects with Hypercalcemia

• Subjects with Hypercalciuria

• Subjects with renal impairment

• Subjects with calcium stone

• Subjects diagnosed with sarcoidosis or pseudo-hypoparathyroidism

• Subjects who are to take vitamin D supplements during the study period